Cetuximab, Capecitabine, Oxaliplatin and Bevacizumab in Advanced Colorectal Cancer
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00208546 |
Recruitment Status :
Completed
First Posted : September 21, 2005
Last Update Posted : February 2, 2012
|
Sponsor:
Dutch Colorectal Cancer Group
Collaborators:
Koningin Wilhelmina Fonds
Sanofi
Roche Pharma AG
Immunicon
Information provided by (Responsible Party):
Dutch Colorectal Cancer Group
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | July 2009 |
Actual Study Completion Date : | December 2009 |
Publications of Results:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):